Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer
Prostate cancer (PC) is the most prevalent male urogenital cancer worldwide. PC patients
presenting an advanced or metastatic cancer succumb to the disease, even after therapeutic …
presenting an advanced or metastatic cancer succumb to the disease, even after therapeutic …
Regulatory roles of six-transmembrane epithelial antigen of the prostate family members in the occurrence and development of malignant tumors
WJ Chen, HT Wu, CL Li, YK Lin, ZX Fang… - Frontiers in Cell and …, 2021 - frontiersin.org
The human six-transmembrane epithelial antigen of the prostate (STEAP) proteins, which
include STEAP1–4 and atypical STEAP1B, contain six transmembrane domains and are …
include STEAP1–4 and atypical STEAP1B, contain six transmembrane domains and are …
STAMP2 expression mediated by cytokines attenuates their growth-limiting effects in prostate cancer cells
Simple Summary Prostate cancer (PCa) is the most common non-skin cancer and one of the
leading causes of cancer death in men. Despite significant developments in therapy options …
leading causes of cancer death in men. Despite significant developments in therapy options …
STAMPing at the crossroads of normal physiology and disease states
The six transmembrane protein of prostate (STAMP) proteins, also known as six
transmembrane epithelial antigen of prostate (STEAPs), comprises three members: STAMP1 …
transmembrane epithelial antigen of prostate (STEAPs), comprises three members: STAMP1 …
Molecular correlates and prognostic value of tmTNF-α expression in colorectal cancer of 5-Fluorouracil-Based Adjuvant Therapy
X Li, S Wang, HJ Ren, J Ma, X Sun, N Li… - Cancer biology & …, 2016 - Taylor & Francis
Transmembrane tumor necrosis factor-α (tmTNF-α) is known to induce the activation of NF-
κB to protect tumor cells. Upregulation of tmTNF-α leads to resistance to apoptosis and …
κB to protect tumor cells. Upregulation of tmTNF-α leads to resistance to apoptosis and …
Peptides and combination of peptides for use in immunotherapy against various cancers
M Andrea, T Weinschenk, S Colette, O Schoor… - US Patent …, 2019 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …
immunotherapeutic methods. In particular, the present invention relates to the …
[HTML][HTML] Electric pulse current stimulation increases electrophysiological properties of If current reconstructed in mHCN4-transfected canine mesenchymal stem cells
Y Feng, S Luo, P Yang, Z Song - Experimental and …, 2016 - spandidos-publications.com
The'funny'current, also known as the If current, play a crucial role in the spontaneous
diastolic depolarization of sinoatrial node cells. The If current is primarily induced by the …
diastolic depolarization of sinoatrial node cells. The If current is primarily induced by the …
Peptides and combination of peptides for use in immunotherapy against various cancers
M Andrea, T Weinschenk, S Colette, O Schoor… - US Patent …, 2019 - Google Patents
2016-12-30 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Peptides and combination of peptides for use in immunotherapy against various cancers
M Andrea, T Weinschenk, S Colette, O Schoor… - US Patent …, 2018 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …
immunotherapeutic methods. In particular, the present invention relates to the …
Peptides and combination of peptides for use in immunotherapy against various cancers
M Andrea, T Weinschenk, S Colette, O Schoor… - US Patent …, 2018 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …
immunotherapeutic methods. In particular, the present invention relates to the …